Samuel J Holzmayer

5PUBLICATIONS
46CO-AUTHORS
Molecular targetsMedical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 19, 2026
Enhancing NK Cell Activity in Colorectal Cancer with an Fc-Optimized Antibody Targeting CD276 (B7-H3).

Sylwia A Stefańczyk, Xenija Kaiser, Ilona Hagelstein

|Oct 03, 2025
FLT3-ITD Induces CMTM6 and Enhances Immune Escape in Acute Myeloid Leukemia.

Melissa Zwick, Bastian Zinkel, Corinna Spohr

|Apr 18, 2024
Induction of NK cell reactivity against acute myeloid leukemia by Fc-optimized CD276 (B7-H3) antibody.

Sylwia A Stefańczyk, Ilona Hagelstein, Martina S Lutz

|Apr 13, 2024
Asciminib Maintains Antibody-Dependent Cellular Cytotoxicity against Leukemic Blasts.

Samuel J Holzmayer, Joseph Kauer, Jonas Mauermann

Pageof 1